3-150410222-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001303264.2(TSC22D2):c.872C>T(p.Pro291Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000693 in 1,574,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001303264.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSC22D2 | NM_001303264.2 | c.872C>T | p.Pro291Leu | missense_variant | 1/3 | ENST00000688009.1 | NP_001290193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSC22D2 | ENST00000688009.1 | c.872C>T | p.Pro291Leu | missense_variant | 1/3 | NM_001303264.2 | ENSP00000510392 | A2 | ||
TSC22D2 | ENST00000361875.8 | c.872C>T | p.Pro291Leu | missense_variant | 1/4 | 1 | ENSP00000354543 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000398 AC: 69AN: 173194Hom.: 0 AF XY: 0.000386 AC XY: 37AN XY: 95936
GnomAD4 exome AF: 0.000724 AC: 1030AN: 1422246Hom.: 0 Cov.: 30 AF XY: 0.000669 AC XY: 471AN XY: 704062
GnomAD4 genome AF: 0.000400 AC: 61AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.000268 AC XY: 20AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.872C>T (p.P291L) alteration is located in exon 1 (coding exon 1) of the TSC22D2 gene. This alteration results from a C to T substitution at nucleotide position 872, causing the proline (P) at amino acid position 291 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at